Briacell Therapeutics Corp

NASDAQ BCTX

Data sourced from iex and EODHD
Download Data

Briacell Therapeutics Corp Income Statement 2006 - 2024

This table shows the Income Statement for Briacell Therapeutics Corp going from 2006 until 2024. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement Trend Unit 2024-01-31 2023-10-31 2023-07-31 2023-04-30 2023-01-31 2022-10-31 2022-07-31 2022-04-30 2022-01-31 2021-10-31 2021-07-31 2021-04-30 2021-01-31 2020-10-31 2020-07-31 2020-04-30 2020-01-31 2019-10-31 2019-07-31 2019-04-30 2019-01-31 2018-10-31 2018-07-31 2018-04-30 2018-01-31 2017-10-31 2017-07-31 2017-04-30 2017-01-31 2016-10-31 2016-07-31 2016-04-30 2016-01-31 2015-10-31 2015-07-31 2015-04-30 2015-01-31 2014-10-31 2014-07-31 2014-04-30 2014-01-31 2013-10-31 2013-07-31 2013-04-30 2013-01-31 2012-10-31 2012-07-31 2012-04-30 2012-01-31 2011-10-31 2011-07-31 2011-04-30 2011-01-31 2010-10-31 2010-07-31 2010-04-30 2010-01-31 2009-10-31 2009-07-31 2009-04-30 2009-01-31 2008-10-31 2008-07-31 2008-04-30 2008-01-31 2007-10-31 2007-07-31 2007-04-30 2007-01-31 2006-10-31 2006-07-31
Revenue
M 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Cost of Revenue
M 0 0 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Gross Profit
M 0 0 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Operating Expenses
M 32 19 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Selling, General, and Administrative Expenses (SG&A)
M 8 7 8 7 7 8 7 6 7 4 4 3 1 1 1 2 2 1 1 1 2 2 1 1 1 1 1 1 1 2 2 2 2 2 1 1 1 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 1 0 0 0 0 0 0 0 0 0 0 - - - - - - - -
Research and Development (R&D) Expenses
M 24 19 15 13 12 10 8 6 4 2 1 1 1 2 2 3 4 4 4 4 3 3 2 2 2 2 2 2 1 1 1 0 0 0 0 0 0 0 0 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Other Operating Expenses
M 0 -8 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Costs and Expenses
M 32 26 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Operating Income
M -32 -19 -16 -12 -4 -11 -8 -6 -13 -9 -7 -6 -2 -3 -4 -4 -5 -5 -5 -5 -5 -4 -4 -3 -3 -3 -3 -2 -1 -2 -2 -2 -2 -2 -1 -1 -1 0 0 0 0 0 0 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Interest Expense
M 15 30 30 16 27 12 12 12 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - - - - - - - - - - - - - - - - - - - - - - 0 0 0 0 - - - 0 0 0 0 0 0 0 0 0 0 - - - 0 0 0 0 0 -
Non-operating Income/Expense
M 19 5 -5 -23 -24 -9 -13 -1 7 15 15 16 8 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 -3 -11 -11 -10 -8 -1 -1 0 0 0 0 -1 -1 -1 0 0 0 0 -1 -1 -1 -1 0 0 0 0 0 0 0 - - - - - - - -
EBT
M -13 -13 -20 -35 -28 -14 -12 6 7 5 4 3 1 1 1 2 2 0 -1 -3 -5 -4 -4 -4 -3 -3 -3 -2 -1 -2 -2 -1 -1 -3 -3 -10 -10 -8 -8 -1 0 0 0 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -2 -2 -2 -1 0 0 0 0 0 0 - - - - - - - -
Income Tax Provision
M -10 -10 0 -5 7 7 12 10 0 -9 -8 -7 -8 0 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 0 1 0 0 0 2 9 17 17 16 8 1 0 0 0 0 0 0 -1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Income after Tax
M -3 -3 -20 -31 -35 -21 -24 -4 7 13 12 10 9 1 1 1 1 -1 -2 -4 -6 -5 -5 -5 -4 -3 -3 -2 -2 -2 -2 -2 -2 -3 -4 -19 -27 -26 -24 -9 -1 0 0 -1 -1 -1 -1 -1 -1 -1 -1 -1 -2 -2 -2 -2 -1 -1 -1 0 0 0 0 - - - - - - - -
Non-Controlling Interest
M 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Net Income
M -5 -17 -18 -34 -34 -26 -27 -14 -5 -2 0 2 -2 -4 -3 -3 -2 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Shares (Basic, Weighted)
M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Shares (Diluted, Weighted)
R 16,039,103.50 15,923,176.75 15,633,958.50 15,448,188.50 15,448,175.00 15,515,877.25 15,478,975.75 15,486,710.00 13,491,372.25 9,737,156.00 6,087,543.50 2,270,330.21 566,653.96 554,153.96 541,653.71 541,635.11 524,776.86 480,696.86 434,633.11 434,601.15 402,479.15 359,584.65 317,721.90 406,421.00 360,521.75 350,353.00 334,616.75 322,040.25 307,410.25 294,669.50 288,448.50 284,901.50 284,280.25 263,248.75 236,897.25 178,941.25 123,333.00 88,509.50 59,006.00 59,006.00 58,967.75 58,928.75 58,925.75 58,922.75 58,919.50 58,917.00 58,843.00 58,769.00 50,307.25 41,485.00 32,672.25 23,859.50 21,902.00 19,989.75 18,103.00 16,216.25 13,505.75 10,739.50 8,097.50 5,455.50 5,084.50 5,084.50 5,084.50 5,084.50 5,721.00 5,721.00 5,824.75 5,928.50 5,443.67 5,747.00 5,747.00
EBITDA
M -46 -33 -15 -25 -17 -18 -12 6 7 5 4 3 1 1 1 2 2 0 -1 -3 -5 -4 -4 -3 -3 -3 -3 -2 -1 -2 -2 -2 -2 0 0 7 8 7 7 0 0 0 0 0 0 0 0 -1 -1 -1 -1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation and Amortization
M 0 0 0 -13 -13 -13 -13 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 -1 -1 -1 -1 0 0 0 0 0 0 0 0 0 -2 -2 -2 -2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
EBIT
M -46 -33 -15 -12 -4 -5 1 6 7 5 4 3 1 1 1 2 2 0 -1 -3 -4 -3 -3 -2 -3 -3 -3 -2 -1 -2 -2 -2 -2 0 2 9 10 9 7 0 0 0 0 0 0 0 0 -1 -1 -1 -1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Income from Discontinued Operations
M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Tax Rate (Effective)
% -107.94 -108.03 49.90 99.62 222.04 221.97 124.87 95.81 -17.52 -1,188.38 -1,174.21 -1,145.09 -1,150.98 29.88 43.42 45.27 67.28 49.15 14.50 19.95 -21.58 -30.65 -32.42 -40.07 -29.72 -37.44 -34.55 -37.67 -47.70 -28.13 -40.31 21.75 30.32 34.80 -357.93 -440.83 -801.83 -954.80 -544.98 -521.60 -158.57 -2.58 5.91 -19.77 0.90 25.82 45.26 70.72 52.39 26.59 -0.54 -27.53 -27.03 -28.66 -6.35 6.78 8.99 13.55 -28.11 -66.89 -66.89 -66.89 -111.01 - - - - - - - -
Earnings Per Share (EPS), Basic
M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Earnings Per Share (EPS), Diluted
M 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Gross Profit Margin
% - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Operating Income Margin
% - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Net Income Margin
% - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
EBITDA Ratio
% - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
EBIT Ratio
% - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
EBT Ratio
% - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

StockViz Staff

September 19, 2024

Any question? Send us an email